Medexus Pharmaceuticals Inc.
Medexus Pharmaceuticals Inc. (MDP.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDP.TO · as of Jun 8, 2026
Key Statistics
Explore Medexus Pharmaceuticals Inc. Data
mdp.to stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
mdp.to competitorsMDP.TO
BNXT.CN
CBST.NE
CRDL.TO
CXXI.CN
DB.VStock Performance
Full HistoryAbout Medexus Pharmaceuticals Inc.
Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. It focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-imm…
what is medexus pharmaceuticals inc. · mdp.to stock overview · medexus pharmaceuticals inc. company profile · who is medexus pharmaceuticals inc. ceo · mdp.to TSX · medexus pharmaceuticals inc. headquarters · medexus pharmaceuticals inc. business segments
About Stock Overview & Key Data
Medexus Pharmaceuticals Inc. (MDP.TO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on TSX since Jan 9, 2014. As of the latest trading session, MDP.TO stock price is $3.94, with a market capitalization of $127.3M. The stock has returned +38.38% over the past 12 months and +35.05% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Medexus Pharmaceuticals Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Medexus Pharmaceuticals Inc. reported revenue of $108.3M and net income of $2.2M. For detailed data — including Medexus Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Medexus Pharmaceuticals Inc. (MDP.TO) stock price is $3.94. The stock is traded on TSX under the ticker symbol MDP.TO. The 52-week range is $2.47 – $4.17.